Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Akso Health GroupAHG +5.63%36 Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus rates AHG with a GF Score™ of 36/100 and a GF Value™ of $0.40 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 99 Medical Distribution companies, Akso Health Group ranks worse than 1010100% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Akso Health Group's Debt-to-Equity or its related term are showing as below:
During the past 12 years, the highest Debt-to-Equity Ratio of Akso Health Group was 0.58. The lowest was 0.00. And the median was 0.29.
AHG's Debt-to-Equity is not ranked *
in the Medical Distribution industry.
Industry Median: 0.48 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Akso Health Group Debt-to-Equity Related Terms
Akso Health Group Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Akso Health Group's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Akso Health Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akso Health Group Debt-to-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Akso Health Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Akso Health Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akso Health Group (AHG) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Akso Health Group and its competitors. According to the industry distribution chart, Akso Health Group ranks #999999 out of 99 companies in the Medical Distribution industry.
Is Akso Health Group's Debt-to-Equity too high?
Akso Health Group's current Debt-to-Equity is 0.00. Based on the distribution chart, Akso Health Group ranks #999999 out of 99 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Akso Health Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's Debt-to-Equity compare to ACH and FOCL?
According to the Medical Distribution industry distribution chart, Akso Health Group ranks #999999 out of 99 companies for Debt-to-Equity. This places Akso Health Group in the lower half of its industry. The industry median Debt-to-Equity is 0.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Distribution company?
The median Debt-to-Equity among Medical Distribution companies is 0.48, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Akso Health Group and its competitors. For the Medical Distribution industry, the median Debt-to-Equity is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akso Health Group's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.40, compared to a current price of $1.43 — trading 256.5% above its estimated fair value. The current Debt-to-Equity is 0.00. Akso Health Group's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Akso Health Group (AHG), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akso Health Group (AHG) Overvalued in 2026?
Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued.
The current stock price of $1.43 is trading 256.5% above its estimated GF Value™ of $0.40.
GuruFocus considers Akso Health Group to be Significantly Overvalued.
Key valuation signals for AHG:
Debt-to-Equity: 0.00
GF Value™: $0.40 vs. price of $1.43 (256.5% above fair value)
No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
36GF Score
Get the complete analysis for AHG
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHG has been successfully added to your 
